Advanced search
Publication Cover
Journal of Medical Economics Volume 25, 2022 - Issue 1
Submit an article Journal homepage
10,065
Views
10
CrossRef citations to date
0
Altmetric
COVID-19

Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States

Manuela Di Fuscoa Health Economics & Outcomes Research, Pfizer Inc, New York, NY, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0079-7331
ORCID Icon,
Kinga Marczellb Evidence, Value & Access by PPD, Evidera, Budapest, Hungary
,
Kristen A. Degerc Modeling and Simulation, Evidera, Bethesda, USA
,
Mary M. Morand Evidera PPD, Ivry-sur-Seine, France
,
Timothy L. Wiemkend Evidera PPD, Ivry-sur-Seine, France
,
Alejandro Canea Health Economics & Outcomes Research, Pfizer Inc, New York, NY, USA
,
Solène de Boisvilliersb Evidence, Value & Access by PPD, Evidera, Budapest, Hungary
,
Jingyan Yanga Health Economics & Outcomes Research, Pfizer Inc, New York, NY, USA;e Institute for Social and Economic Research and Policy, Columbia University, New York, NY, USA
,
Shailja Vaghelaf HEOR, HealthEcon Consulting, Inc, Ancaster, ON, Canada
&
Julie Roizg Evidence, Value & Access by PPD, Evidera, London, UK
 show all
Pages 605-617 | Received 04 Apr 2022, Accepted 25 Apr 2022, Published online: 15 May 2022

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Mitsuhiro Nagano, Kazumasa Kamei, Hiroyuki Matsuda, Chihiro Takahashi, Jingyan Yang, Koji Wada & Naohiro Yonemoto. (2024) Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan. Expert Review of Vaccines 23:1, pages 349-361.
Read now
Karan Thakkar, Julia Spinardi, Moe H. Kyaw, Jingyan Yang, Carlos Fernando Mendoza, Egemen Ozbilgili, Bulent Taysi, Josie Dodd, Ben Yarnoff & Helen M Oh. (2024) Modelling the Potential Public Health Impact of Different COVID-19 Vaccination Strategies with an Adapted Vaccine in Singapore. Expert Review of Vaccines 23:1, pages 16-26.
Read now
J. P. Sevilla. (2024) COVID-19 vaccines should be evaluated from the societal perspective. Journal of Medical Economics 27:1, pages 1-9.
Read now
Karan Thakkar, Julia Spinardi, Moe H. Kyaw, Jingyan Yang, Carlos Fernando Mendoza, Egemen Ozbilgili, Josie Dodd, Ben Yarnoff & Suda Punrin. (2023) Modelling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Thailand. Expert Review of Vaccines 22:1, pages 860-870.
Read now
Karan Thakkar, Julia Spinardi, Moe H. Kyaw, Jingyan Yang, Carlos Fernando Mendoza, Mohan Dass, William Law, Egemen Ozbilgili & Ben Yarnoff. (2023) Modeling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Malaysia. Expert Review of Vaccines 22:1, pages 714-725.
Read now
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela Di Fusco, Timothy Lee Wiemken, Moe H. Kyaw, John M. McLaughlin & Jennifer L. Nguyen. (2023) Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert Review of Vaccines 22:1, pages 54-65.
Read now
Manuela Di Fusco, Kinga Marczell, Elizabeth Thoburn, Timothy L. Wiemken, Jingyan Yang & Benjamin Yarnoff. (2023) Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United States. Journal of Medical Economics 26:1, pages 509-524.
Read now
Ivo Abraham, Kenneth K. C. Lee & Mike Gregg. (2023) Journal of Medical Economics in review: high impact articles from 2022. Journal of Medical Economics 26:1, pages 303-307.
Read now

Articles from other publishers (2)

Oscar Espinosa, Laura Mora, Cristian Sanabria, Antonio Ramos, Duván Rincón, Valeria Bejarano, Jhonathan Rodríguez, Nicolás Barrera, Carlos Álvarez-Moreno, Jorge Cortés, Carlos Saavedra, Adriana Robayo & Oscar H. Franco. (2024) Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review. Systematic Reviews 13:1.
Crossref
Lavinia M Lewis, Advait V Badkar, David Cirelli, Rodney Combs & Thomas F Lerch. (2023) The Race to Develop the Pfizer-BioNTech COVID-19 Vaccine: From the Pharmaceutical Scientists’ Perspective. Journal of Pharmaceutical Sciences 112:3, pages 640-647.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.